Genoway SA
PAR:ALGEN

Watchlist Manager
Genoway SA Logo
Genoway SA
PAR:ALGEN
Watchlist
Price: 2.46 EUR -0.4% Market Closed
Market Cap: 23.3m EUR

Wall Street
Price Targets

ALGEN Price Targets Summary
Genoway SA

Wall Street analysts forecast ALGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALGEN is 6.02 EUR with a low forecast of 5.96 EUR and a high forecast of 6.2 EUR.

Lowest
Price Target
5.96 EUR
142% Upside
Average
Price Target
6.02 EUR
145% Upside
Highest
Price Target
6.2 EUR
152% Upside
Genoway SA Competitors:
Price Targets
ALNY
Alnylam Pharmaceuticals Inc
25% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
35% Upside
ALDX
Aldeyra Therapeutics Inc
117% Upside
BMEA
Biomea Fusion Inc
406% Upside
ACLX
Arcellx Inc
59% Upside
AUPH
Aurinia Pharmaceuticals Inc
8% Upside
PGEN
Precigen Inc
135% Upside

Revenue
Forecast

Revenue Estimate
Genoway SA

For the last 13 years the compound annual growth rate for Genoway SA's revenue is 8%. The projected CAGR for the next 3 years is 14%.

8%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Genoway SA

For the last 13 years the compound annual growth rate for Genoway SA's operating income is 13%. The projected CAGR for the next 3 years is -7%.

13%
Past Growth
-7%
Estimated Growth
Estimates Accuracy
-39%
Average Miss

Net Income
Forecast

Net Income Estimate
Genoway SA

For the last 13 years the compound annual growth rate for Genoway SA's net income is 10%. The projected CAGR for the next 3 years is -19%.

10%
Past Growth
-19%
Estimated Growth
Estimates Accuracy
-37%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALGEN's stock price target?
Price Target
6.02 EUR

According to Wall Street analysts, the average 1-year price target for ALGEN is 6.02 EUR with a low forecast of 5.96 EUR and a high forecast of 6.2 EUR.

What is Genoway SA's Revenue forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for Genoway SA's revenue is 8%. The projected CAGR for the next 3 years is 14%.

What is Genoway SA's Operating Income forecast?
Projected CAGR
-7%

For the last 13 years the compound annual growth rate for Genoway SA's operating income is 13%. The projected CAGR for the next 3 years is -7%.

What is Genoway SA's Net Income forecast?
Projected CAGR
-19%

For the last 13 years the compound annual growth rate for Genoway SA's net income is 10%. The projected CAGR for the next 3 years is -19%.

Back to Top